Trials / Completed
CompletedNCT03184740
Physical Performance and Analgesic Effects of tDCS in Primary Dysmenorrhea
Physical Performance and Analgesic Effects of tDCS in Primary Dysmenorrhea: A Randomized, Double Blind Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Universidade Federal do Rio Grande do Norte · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Technological advances and non-invasive techniques to modulate brain function have been developed, including transcranial Direct Current Stimulation (tDCS). Basically, electrodes are placed on the brain regions to stimulate or inhibit it. Subsequently, a continuous electrical current (0.4-2 mA) is imposed, for a period of 3-20 minutes, to modify cortical excitability. Few are the research groups that work on the topic of primary dysmenorrhea and the use of tDCS as the focus of study. Preliminary studies associated the use of tDCS with pain reduction, but the outcomes of physical and behavioral function needs further investigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active Transcranial Direct Current Stimulation | For electrode placement, the criteria used by the 10/20 electroencephalography system will be obeyed and the electrodes will be positioned over Primary motor cortex, C3 area for the anode and Fp2 (contralateral supraorbital area) for the cathode electrode. A constant current of 2mA will be applied for 20 minutes. |
| DEVICE | Sham Transcranial Direct Current Stimulation | For electrode placement, the criteria used by the 10/20 electroencephalography system will be obeyed and the electrodes will be positioned over primary motor cortex, C3 area for the anode and Fp2 (contralateral supraorbital area) for the cathode electrode, but the stimulator will be turned off after 30 seconds of stimulation. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2017-07-31
- Completion
- 2017-08-31
- First posted
- 2017-06-14
- Last updated
- 2017-09-12
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03184740. Inclusion in this directory is not an endorsement.